TGFβ1, SMAD and β-catenin in pulmonary arteries of smokers, patients with small airway disease and COPD: potential drivers of EndMT
Clinical Science · 04.09.2024 · 138 (17) · 1055-1070
DOI: 10.1042/cs20240721 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, online erschienen am 28.08.2024. Verfasst von Prem Bhattarai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, beta Catenin, Transforming Growth Factor beta1, Pulmonary Artery. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: Clifford Craig Foundation.
Themen: COPD
Abstract (Originalsprache)
We previously reported pulmonary arterial remodelling and active endothelial-to-mesenchymal transition (EndMT) in smokers and patients with early chronic obstructive pulmonary disease (COPD). In the present study, we aimed to evaluate the role of different drivers of EndMT. Immunohistochemical staining for EndMT drivers, TGF-β1, pSMAD-2/3, SMAD-7, and β-catenin, was performed on lung resections from 46 subjects. Twelve were non-smoker-controls (NC), six normal lung function smokers (NLFS), nine patients with small-airway diseases (SAD), nine mild-moderate COPD-current smokers (COPD-CS) and ten COPD-ex-smokers (COPD-ES). Histopathological measurements were done using Image ProPlus softwarev7.0. We observed lower levels of total TGF-β1 (P<0.05) in all smoking groups than in the non-smoking control (NC). Across arterial sizes, smoking groups exhibited significantly higher (P<0.05) total and individual layer pSMAD-2/3 and SMAD-7 than in the NC group. The ratio of SAMD-7 to pSMAD-2/3 was higher in COPD patients compared with NC. Total β-catenin expression was significantly higher in smoking groups across arterial sizes (P<0.05), except for COPD-ES and NLFS groups in small and medium arteries, respectively. Increased total β-catenin was positively correlated with total S100A4 in small and medium arteries (r = 0.35, 0.50; P=0.02, 0.01, respectively), with Vimentin in medium arteries (r = 0.42, P=0.07), and with arterial thickness of medium and large arteries (r = 0.34, 0.41, P=0.02, 0.01, respectively). This is the first study uncovering active endothelial SMAD pathway independent of TGF-β1 in smokers, SAD, and COPD patients. Increased expression of β-catenin indicates its potential interaction with SMAD pathway, warranting further research to identify the deviation of this classical pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7248, Australia.
- Department of Cardiothoracic Surgery, Royal Hobart Hospital, Hobart, Tasmania 7000, Australia.
- Department of Cardiothoracic Surgery, The Royal Adelaide Hospital, Adelaide South Australia, 5000 Australia.
- Department of Anaesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada.
- Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.
ORCID-Profile: Mathew S Eapen
Förderung
- Clifford Craig Foundation
Zitieren
APA
Bhattarai, P., Lu, W., Hardikar, A., Gaikwad, A. V., Dey, S., Shahzad, A. M., Myers, S., Williams, A., Sutherland, D., Singhera, G. K., Hackett, T. L., Eapen, M. S., & Sohal, S. S. (2024). TGFβ1, SMAD and β-catenin in pulmonary arteries of smokers, patients with small airway disease and COPD: potential drivers of EndMT. Clinical Science, 138(17), 1055-1070. https://doi.org/10.1042/cs20240721
Vancouver
Bhattarai P, Lu W, Hardikar A, Gaikwad AV, Dey S, Shahzad AM, et al. TGFβ1, SMAD and β-catenin in pulmonary arteries of smokers, patients with small airway disease and COPD: potential drivers of EndMT. Clinical Science. 2024;138(17):1055-1070. doi:10.1042/cs20240721
BibTeX
@article{Bhattarai2024,
author = {Bhattarai, Prem and Lu, Wenying and Hardikar, Ashutosh and Gaikwad, Archana Vijay and Dey, Surajit and Shahzad, Affan Mahmood and Myers, Stephen and Williams, Andrew and Sutherland, Darren and Singhera, Gurpreet Kaur and Hackett, Tillie-Louise and Eapen, Mathew S and Sohal, Sukhwinder Singh},
title = {TGFβ1, SMAD and β-catenin in pulmonary arteries of smokers, patients with small airway disease and COPD: potential drivers of EndMT},
journal = {Clinical Science},
year = {2024},
volume = {138},
number = {17},
pages = {1055--1070},
doi = {10.1042/cs20240721}
}
EUVIMED